Soymorphin-5, a soy-derived μ-opioid peptide, decreases glucose and triglyceride levels through activating adiponectin and PPARα systems in diabetic KKA y mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 302, Issue 4, 2012, Pages

  Yamada, Yuko ^a   Muraki, Aya ^a   Oie, Mariko ^a   Kanegawa, Norimasa ^a   Oda, Ayako ^a   Sawashi, Yurina ^a   Kaneko, Kentaro ^a   Yoshikawa, Masaaki ^b   Goto, Tsuyoshi ^a   Takahashi, Nobuyuki ^a   Kawada, Teruo ^a   Ohinata, Kousaku ^a  

^a KYOTO UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT   (Japan)

Author keywords

Adiponectin; Blood glucose; Insulin resistance; Peroxisome proliferator activated receptor a; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; GLUCOSE; INSULIN; MESSENGER RNA; MU OPIATE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SOYMORPHIN 5; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; CONTROLLED STUDY; DIABETIC KKAGAMMA MOUSE; DRUG EFFICACY; ENERGY EXPENDITURE; ENZYME ACTIVATION; FATTY ACID OXIDATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIVER WEIGHT; LONG TERM CARE; MALE; MAZE TEST; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOYBEAN; TRANQUILIZING ACTIVITY; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ACYL-COA OXIDASE; ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; CARNITINE O-PALMITOYLTRANSFERASE; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN; ION CHANNELS; LIVER; MALE; MICE; MITOCHONDRIAL PROTEINS; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; PPAR ALPHA; RECEPTORS, ADIPONECTIN; SOYBEAN PROTEINS; TRIGLYCERIDES;

EID: 84856601297     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00161.2011     Document Type: Article

References (47)

1. Akagiri S, Naito Y, Ichikawa H, Mizushima K, Takagi T, Handa O, Kokura S, Yoshikawa T. Bofutsushosan, an oriental herbal medicine, attenuates the weight gain of white adipose tissue and the increased size of adipocytes associated with the increase in their expression of uncoupling protein 1 in high-fat diet-fed male KK/Ta mice. J Clin Biochem Nutr 42: 158-166, 2008.
2. Asakawa A, Inui A, Momose K, Ueno N, Fujino MA, Kasuga M. Endomorphins have orexigenic and anxiolytic activities in mice. Neuroreport 13: 2265-2267, 1998.
3. Brantl V, Teschemacher H, Henschen A, Lottspeich F. Novel opioid peptides derived from casein (_-casomorphins). I. Isolation from bovine casein peptone. Hoppe Seylers Z Physiol Chem 360: 1211-1216, 1979.
4. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953, 2001.
5. Chakass D, Philippe D, Erdual E, Dharancy S, Malapel M, Dubuquoy C, Thuru X, Gay J, Gaveriaux-Ruff C, Dubus P, Mathurin P, Kieffer BL, Desreumaux P, Chamaillard M. α-Opioid receptor activation prevents acute hepatic inflammation and cell death. Gut 56: 974-981. 2007.
6. Chung MJ, Cho SY, Bhuiyan MJ, Kim KH, Lee SJ. Anti-diabetic effects of lemon balm (Melissa officinalis) essential oil on glucose-and lipid-regulating enzymes in type 2 diabetic mice. Br J Nutr 104: 180-188, 2010.
7. Hayashi K, Hayashi T, Iwanaga S, Kawai K, Ishii H, Shoji S, Murakami K. Laughter lowered the increase in postprandial blood glucose. Diabetes Care 26: 1651-1652, 2003.
8. Hirata H, Sonoda S, Agui S, Yoshida M, Ohinata K, Yoshikawa M. Rubiscolin-6, a opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating 1 and dopamine D1 receptors. Peptides 28: 1998-2003, 2007.
9. Hiyoshi H, Yanagimachi M, Ito M, Yasuda N, Okada T, Ikuta H, Shinmyo D, Tanaka K, Kurusu N, Yoshida I, Abe S, Saeki T, Tanaka H. Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes. J. Lipid Res 44; 128-135, 2003.
10. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2_) and AMPK/SIRT1. Nature 464: 1313-1319, 2010.
11. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 8: 51, 2007.
12. Kanegawa N, Suzuki C, Ohinata K. Dipeptide Tyr-Leu (YL) exhibits anxiolytic-like activity after oral administration via activating serotonin 5-HT1A, dopamine D1 and GABAA receptors in mice. FEBS Lett 584: 599-604, 2010.
13. Kaneko K, Iwasaki M, Yoshikawa M, Ohinata K. Orally administered soymorphins, soy-derived opioid peptides, suppress feeding and intestinal transit via gut 1-receptor coupled to 5-HT1A, D2, and GABAB systems. Am J Physiol Gastrointest Liver Physiol 299: G799-G805, 2010.
14. Kim YI, Hirai S, Takahashi H, Goto T, Ohyane C, Tsugane T, Konishi C, Fujii T, Inai S, Iijima Y, Aoki K, Shibata D, Takahashi N, Kawada T. 9-Oxo-10(E),12(E)-octadecadienoic acid derived from tomato is a potent peroxisome proliferator-activated receptor a agonist to decrease triglyceride accumulation in mouse primary hepatocytes. Mol Nutr Food Res 55: 585-593, 2011.
15. Kuwabara K, Murakami K, Todo M, Aoki T, Asaki T, Murai M, Yano J. A novel selective peroxisome proliferator-activated receptor agonist, 2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid (NS-220), potently decreases plasma triglyceride and glucose levels and modifies lipoprotein profiles in KKAy mice. J Pharmacol Exp Ther 309: 970-977, 2004.
16. Li D, Olszewski PK, Shi Q, Grace MK, Billington CJ, Kotz CM, Levine AS. Effect of opioid receptor ligands injected into the rostral lateral hypothalamus on c-fos and feeding behavior. Brain Res 1096: 120-124, 2006.
17. Masuda Y, Haramizu S, Oki K, Ohnuki K, Watanabe T, Yazawa S, Kawada T, Hashizume S, Fushiki T. Upregulation of uncoupling proteins by oral administration of capsiate, a nonpungent capsaicin analog. J Appl Physiol 95: 2408-2415, 2003.
18. Matoba N, Usui H, Fujita H, Yoshikawa M. A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Lett 452: 181-184, 1999.
19. Miura Y, Hosono M, Oyamada C, Odai H, Oikawa S, Kondo K. Dietary isohumulones, the bitter components of beer, raise plasma HDLcholesterol levels and reduce liver cholesterol and triacylglycerol contents similar to PPARalpha activations in C57BL/6 mice. Br J Nutr 93: 559-567, 2005.
20. Moriyama T, Kishimoto K, Nagai K, Urade R, Ogawa T, Utsumi S, Maruyama N, Maebuchi M. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci Biotechnol Biochem 68: 352-359, 2004.
21. Nagasawa A, Fukui K, Funahashi T, Maeda N, Shimomura I, Kihara S, Waki M, Takamatsu K, Matsuzawa Y. Effects of soy protein diet on the expression of adipose genes and plasma adiponectin. Horm Metab Res 34: 635-639, 2002.
22. Nagasawa A, Fukui K, Kojima M, Kishida K, Maeda N, Nagaretani H, Hibuse T, Nishizawa H, Kihara S, Waki M, Takamatsu K, Funahashi T, Matsuzawa Y. Divergent effects of soy protein diet on the expression of adipocytokines. Biochem Biophys Res Commun 311: 909-914, 2003.
23. Nonogaki K, Nozue K, Oka Y. Social isolation affects the development of obesity and type 2 diabetes in mice. Endocrinology 148: 4658-4666, 2007.
24. Ohinata K, Sonoda S, Inoue N, Yamauchi R, Wada K, Yoshikawa M. α-Lactotensin, a neurotensin agonist peptide derived from bovine α-lactoglobulin, enhances memory consolidation in mice. Peptides 28: 1470-1474, 2007.
25. Ohinata K, Agui Yoshikawa MS. Soymorphins, novel opioid peptides derived from soy α-conglycinin α-subunit, have anxiolytic activities. Biosci Biotechnol Biochem 71: 2618-2621, 2007.
26. Ohinata K, Takagi K, Biyajima K, Fujiwara Y, Fukumoto S, Eguchi N, Urade Y, Asakawa A, Fujimiya M, Inui A, Yoshikawa M. Central prostaglandin D2 stimulates food intake via the neuropeptide Y system in mice. FEBS Lett 582: 679-684, 2008.
27. Samuel VT, Choi CS, Phillips TG, Romanelli AJ, Geisler JG, Bhanot S, McKay R, Monia B, Shutter JR, Lindberg RA, Shulman GI, Veniant MM. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55: 2042-2050, 2006.
28. Tachibana N, Iwaoka Y, Hirotsuka M, Horio F, Kohno M. α-Conglycinin lowers very-low-density lipoprotein-triglyceride levels by increasing adiponectin and insulin sensitivity in rats. Biosci Biotechnol Biochem 74: 1250-1255, 2010.
29. Takahashi N, Kawada T, Goto T, Yamamoto T, Taimatsu A, Matsui N, Kimura K, Saito M, Hosokawa M, Miyashita K, Fushiki T. Dual action of isoprenols from herbal medicines on both PPAR and PPAR in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett 514: 315-322, 2002.
30. Takahashi N, Kawada T, Goto T, Kim CS, Taimatsu A, Egawa K, Yamamoto T, Jisaka M, Nishimura K, Yokota K, Yu R, Fushiki T. Abietic acid activates peroxisome proliferator-activated receptor-(PPAR) in RAW264.7 macrophages and 3T3-L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism. FEBS Lett 550: 190-194, 2003.
31. Tzeng TF, Lo CY, Cheng JT, Liu IM. Activation of mu-opioid receptors improves insulin sensitivity in obese Zucker rats. Life Sci 80:1508-1516, 2007.
32. Ueno N, Asakawa A, Satoh Y, Inui A. Increased circulating cholecystokinin contributes to anorexia and anxiety behavior in mice overexpressing pancreatic polypeptide. Regul Pept 141: 8-11, 2007.
33. Uemura T, Goto T, Kang MS, Mizoguchi N, Hirai S, Lee JY, Nakano Y, Shono J, Hoshino S, Taketani K, Tsuge N, Narukami T, Makishima M, Takahashi N, Kawada T. Diosgenin, the Main aglycon of fenugreek, inhibits LXR activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese, diabetic mice. J Nutr 141: 17-23, 2011.
34. Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113: 1408-1418, 2004.
35. Xia FZ, Lu YL, Chen Y, Gu T, Zhang HX, Yu J, Zhao LJ. Peripheral endomorphin-1 levels are suppressed in diabetic patients. Diabetes Res Clin Pract 87: 200-203, 2010.
36. Xu J, Xu M, Rossi GC, Pasternak GW, Pan YX. Identification and characterization of seven new exon 11-associated splice variants of the rat opioid receptor gene, OPRM1. Mol Pain 7: 9, 2011.
37. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946, 2001.
38. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295, 2002.
39. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769, 2003.
40. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, Kawamoto S, Kubota N, Kubota T, Ito Y, Kamon J, Tsuchida A, Kumagai K, Kozono H, Hada Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Awazawa M, Takamoto I, Froguel P, Hara K, Tobe K, Nagai R, Ueki K, Kadowaki T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13: 332-339, 2007.
41. Yamauchi R, Ohinata K, Yoshikawa M. α-Lactotensin and neurotensin rapidly reduce serum cholesterol via NT2 receptor. Peptides 24: 1955-1961, 2003.
42. Yang S, Kawamura Y, Yoshikawa M. Effect of rubiscolin, a delta opioid peptide derived from Rubisco, on memory consolidation. Peptides 24: 325-328, 2003.
43. Yang S, Yunden J, Sonoda S, Doyama N, Lipkowski AW, Kawamura Y, Yoshikawa M. Rubiscolin, a selective opioid peptide derived from plant Rubisco. FEBS Lett 509: 213-217, 2001.
44. Yoshikawa M, Yoshikatsu Y, CHima H. Opioid peptides from human α-casein. Agric Bil Chem 48: 3185-3187, 1984.
45. Zhao H, Usui H, Ohinata K, Yoshikawa M. Met-Arg-Trp derived from Rubisco lowers blood pressure via prostaglandin D2-dependent vasorelaxation in spontaneously hypertensive rats. Peptides 29: 345-349, 2008.
46. Zhao H, Ohinata K, Yoshikawa M. Rubimetide (Met-Arg-Trp) derived from Rubisco exhibits anxiolytic-like activity via the DP1 receptor in male ddY mice. Peptides 29: 629-632, 2008.
47. Zhao H, Ohinata K, Yoshikawa M. Central prostaglandin D2 exhibits anxiolytic-like activity via the DP1 receptor in mice. Prostaglandins Other Lipid Mediat 88: 68-72, 2009.